Oxidative stress in brain aging: Implications for therapeutics of neurodegenerative diseases

Neurobiology of Aging

Volumn 23, Issue 5, 2002, Pages 795-807

  Floyd, Robert A ^a,b   Hensley, Kenneth ^a  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

8 Oxo guanosine; Alzheimer's disease; Brain aging; Cognitive impairment; Hydroxynonenal; Isoprostanes; Neuroinflammation; Nitrones; Oxidative damage; Protein oxidation; Stroke; Vitamin E

Indexed keywords

4 HYDROXYNONENAL; ALPHA TOCOPHEROL; AMYLOID BETA PROTEIN; ANTIOXIDANT; CPI 1189; ENZYME; IBUPROFEN; INDOMETACIN; MITOCHONDRIAL ENZYME; NITRONE DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEIN; REACTIVE OXYGEN METABOLITE; TOXIN; UNCLASSIFIED DRUG;

AGE; AGING; ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BRAIN; COGNITION; DEGENERATIVE DISEASE; DISEASE COURSE; DNA DAMAGE; ENCEPHALITIS; ENERGY EXPENDITURE; ENZYME ACTIVITY; EVALUATION; HUMAN; LIPID OXIDATION; MULTIINFARCT DEMENTIA; NERVE CELL; NERVE CELL NECROSIS; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; VACCINATION; VITAMIN SUPPLEMENTATION;

AGED; AGING; BRAIN; HUMANS; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS;

EID: 0036751954     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(02)00019-2     Document Type: Article

References (121)

1. Agarwal S., Sohal R.S. Aging and proteolysis of oxidized proteins. Arch. Biochem. Biophys. 309:1994;24-28.
2. Aksenova M.V., Askenov M.Y., Carney J.M., Butterfield D.A. Protein oxidation and enzyme activity decline in old Brown-Norway rats are reduced by dietary restriction. Mech. Ageing Dev. 100:1998;157-168.
3. Bosch-Morell F., Flohe L., Marin N., Romero F.J. 4-Hydroxynonenal inhibits glutathione peroxidase: protection by glutathione. Free Radic. Biol. Med. 26:1999;1383-1387.
4. Boschi-Muller S., Azza S., Sanglier-Cianferani S., Talfournier F., Van Dorsselear A., Granlant G. A sulfenic acid enzyme intermediate is involved in the catalytic mechanism of peptide methionine sulfoxide reductase from Escherichia coli. J. Biol. Chem. 275:2000;35908-35913.
5. Cakatay U., Telci A., Kayali R., Tekeli F., Akcay T., Sivas A. Relation of oxidative protein damage and nitrotyrosine levels in the aging rat brain. Exp. Gerontol. 36:2001;221-229.
6. Cao W., Carney J.M., Duchon A., Floyd R.A., Chevion M. Oxygen free radical involvement in ischemia and reperfusion injury to brain. Neurosci. Lett. 88:1988;233-238.
7. Chen J.J., Yu B.P. Detoxification of reactive aldehydes in mitochondria: effects of age and dietary restriction. Aging. 8:1996;334-340.
8. Cherny R.A., Atwood C.S., Xilinas M.E., Gray D.N., Jones W.D., McLean C.A.et al. Treatment with a copper-zinc chelator markedly and rapidly inhibits β-amyloid accumulation in Alzheimer's disease transgenic mice. Neuron. 30:2001;665-676.
9. Copani A., Condorelli F., Caruso A., Vancheri C., Sala A., Giuffrida Stella A.M.et al. Mitotic signaling by β-amyloid causes neuronal death. FASEB J. 13:1999;2225-2234.
10. Davies K.J.A. Degradation of oxidized proteins by the 20S proteasome. Biochimie. 83:2001;301-310.
11. Davies S.M.K., Poljak A., Duncan M.W., Smythe G.A., Murphy M.P. Measurements of protein carbonyls, ortho- and meta-tyrosine and oxidative phosphorylation complex activity in mitochondria from young and old rats. Free Radic. Biol. Med. 31:2001;181-190.
12. Del Corso A., Dal Monte M., Vilardo P.G., Cecconi I., Moschini R., Banditelli S.et al. Site-specific inactivation of aldose reductase by 4-hydroxynonenal. Arch. Biochem. Biophys. 350:1998;245-248.
13. Denu J.M., Tanner K.G. Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: evidence for a sulfenic acid intermediate and implications for redox regulation. Biochemistry. 37:1998;5633-5642.
14. Dorheim M.-A., Tracey W.R., Pollock J.S., Grammas P. Nitric oxide synthase activity is elevated in brain microvessels in Alzheimer's disease. Biochem. Biophys. Res. Commun. 205:1994;659-665.
15. Dubey A., Forster M.J., Sohal R.S. Effect of spin-trapping compound N-tert-butyl-α-phenylnitrone on protein oxidation and life span. Arch. Biochem. Biophys. 324:1995;249-254.
16. Durany N., Munch G., Michel T. Investigations on oxidative stress and therapeutical implications in dementia. Eur. Arch. Psychiatr. Clin. Neurosci. 249:1999;III68-III73.
17. Eikelenboom P., Veerhuis R. The role of complement and activated microglia in the pathogenesis of Alzheimer's disease. Neurobiol. Aging. 17:1996;673-680.
18. Endoh H., Kato N., Fujii S., Suzuki Y., Sato S., Kayama T.et al. Spin trapping agent, phenyl N-tert-butylnitrone, reduces nitric oxide production in the rat brain during experimental meningitis. Free Radic. Res. Commun. 35:2001;583-591.
19. Esterbauer H., Schaur R.J., Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 11:1991;81-128.
20. Farkas E., Luiten P.G.M. Cerebral microvascular pathology in aging and Alzheimer's disease. Prog. Neurobiol. 64:2001;575-611.
21. Ferrini M., Wang C., Swerdloff R.S., Hikim A.P.S., Rajfer J., Gonzalez-Cadavid N.F. Aging-related increased expression of inducible nitric oxide synthase and cytotoxicity markers in rat hypothalamic regions associated with male reproductive function. Neuroendocrinology. 74:2001;1-11.
22. Finch C.E., Marchalonis J.J. Evolutionary perspectives on amyloid and inflammatory features of Alzheimer's disease. Neurobiol. Aging. 17:1996;809-815.
23. Floyd R.A., Carney J.M. Age influence on oxidative events during brain ischemia/reperfusion. Arch. Gerontol. Geriatr. 12:1991;155-177.
24. Floyd R.A., Carney J.M. Free radical damage to protein and DNA: mechanisms involved and relevant observations on brain undergoing oxidative stress. Ann. Neurol. 32:1992;S22-S27.
25. Floyd R.A. Antioxidants, oxidative stress, and degenerative neurological disorders. Proc. Soc. Exp. Biol. Med. 222:1999;236-245.
26. Floyd R.A., West M.S., Eneff K.L., Schneider J.E., Wong P.K., Tingey D.T.et al. Conditions influencing yield and analysis of 8-hydroxy-2′-deoxyguanosine in oxidatively damaged DNA. Anal. Biochem. 188:1990;155-158.
27. Floyd R.A., West M., Hensley K. Oxidative biochemical markers clues to understanding aging in long-lived species. Exp. Gerontol. 36:2001;619-640.
28. Floyd R.A. Role of oxygen free radicals in carcinogenesis and brain ischemia. FASEB J. 4:1990;2587-2597.
29. Floyd R.A., Watson J.J., Wong P.K., Altmiller D.H., Rickard R.C. Hydroxyl free radical adduct of deoxyguanosine: sensitive detection and mechanisms of formation. Free Radic. Res. Commun. 1:1986;163-172.
30. Floyd R.A., West M.S., Eneff K.L., Hogsett W.E., Tingey D.T. Hydroxyl free radical mediated formation of 8-hydroxyguanine in isolated DNA. Arch. Biochem. Biophys. 262:1988;266-272.
31. Floyd R.A. Neuroinflammatory processes are important in neurodegenerative diseases: an hypothesis to explain the increased formation of reactive oxygen and nitrogen species as major factors involved in neurodegenerative disease development. Free Radic. Biol. Med. 26:1999;1346-1355.
32. Floyd R.A., Hensley K., Bing G. Evidence for enhanced neuroinflammatory processes in neurodegenerative diseases and the action of nitrones as potential therapeutics. J. Neural. Transm. 60:2000;337-364.
33. Floyd RA, Carney JM. Nitrone radical traps protect in experimental neurodegenerative diseases. In: Chapman CA, Olanow CW, Jenner P, Youssim M, editors. Neuroprotective approaches to the treatment of Parkinson's disease and other neurodegenerative disorders. London: Academic Press, 1996. p. 69-90.
34. Floyd RA, Hensley K, Forster MJ, Kelleher-Anderson JA, Wood PL. Nitrones, their value as therapeutics and probes to understand aging. Mech Ageing Dev 2001, in press.
35. Floyd R.A. Protective action of nitrone-based free radical traps against oxidative damage to the central nervous system. Adv. Pharmacol. 38:1997;361-378.
36. Gabbita S.P., Aksenov M.Y., Lovell M.A., Markesbery W.R. Decrease in peptide methionine sulfoxide reductase in Alzheimer's disease brain. J. Neurochem. 73:1999;1660-1666.
37. Giovanni A., Wirtz-Brugger F., Keramaris E., Slack R., Park D.S. Involvement of cell cycle elements, cyclin-dependent kinases, pRb, and E2F-DP, in β-amyloid-induced neuronal death. J. Biol. Chem. 27:1999;19011-19016.
38. Gordon M.N., Schreier W.A., Ou X., Holcomb L.A., Morgan D.G. Exaggerated astrocyte reactivity after nigrostriatal deafferentation in the aged rat. J. Comp. Neurol. 388:1997;106-119.
39. Graga C.G., Shigenaga M.K., Park J.-W., Degan P., Ames B.N. Oxidation damage to DNA during aging: 8-hydroxy-2′-deoxyguanosine in rat organ DNA and urine. Proc. Natl. Acad. Sci. USA. 87:1990;4533-4537.
40. Grammas P., Liu G.-J., Wood K., Floyd R.A. Anoxia/reoxygenation induces hydroxyl free radical formation in brain microvessels. Free Radic. Biol. Med. 14:1993;553-557.
41. Grundman M. Vitamin E and Alzheimer's disease: the basis for additional clinical trials. Am. J. Clin. Nutr. 71S:2000;630S-636S.
42. Guichardant M., Taibi-Tronche P., Fay L.B., Lagarde M. Covalent modifications of aminophospholipids by 4-hydroxynonenal. Free Radic. Biol. Med. 25:1998;1049-1056.
43. Hamilton M.L., Guo Z., Fuller C.D., Van Remmen H., Ward W.F., Austad S.N.et al. A reliable assessment of 8-oxo-2-deoxyguanosine levels in nuclear and mitochondrial DNA using the sodium iodide method to isolate DNA. Nucleic Acids Res. 29:2001;2117-2126.
44. Hamilton M.L., Van Remmen H., Drake J.A., Yang H., Guo Z., Kewitt K.et al. Does oxidative damage to DNA increase with age? Proc. Natl. Acad. Sci. USA. 98:2001;10469-10474.
45. Helbock H.J., Beckman K.B., Shigenaga M.K., Walter P.B., Woodall A.A., Yeo H.C.et al. DNA oxidation matters: the HPLC-electrochemical detection assay of 8-oxo-deoxyguanosine and 8-oxo-guanine. Proc. Natl. Acad. Sci. USA. 95:1998;288-293.
46. Helbock H.J., Beckman K.B., Ames B.N. 8-Hydroxydeoxyguanosine and 8-hydroxyguanine as biomarkers of oxidative DNA damage. Methods Enzymol. 300:1999;156-166.
47. Hensley K, Maidt L, Stewart CA, Pye QN, Robinson KA, Floyd RA. Mitochondrial alteration in aging and inflammation: a possible site of action of nitrone-based free radical traps. In: Cadenas E, Packer L, editors. Understanding the process of aging the roles of mitochondria, free radicals, and antioxidants. New York: Marcel Dekker, 1999. p. 311-25.
48. Hensley K., Pye Q.N., Maidt M.L., Stewart C.A., Robinson K.A., Jaffrey F.et al. Interaction of α-phenyl-N-tert-butylnitrone and alternative electron acceptors with complex I indicates a substrate reduction site upstream from the rotenone binding site. J. Neurochem. 71:1998;2549-2557.
49. Hensley K., Williamson K.S., Maidt M.L., Gabbita S.P., Grammas P., Floyd R.A. Determination of biological oxidative stress using high performance liquid chromatography with electrochemical detection (HPLC-ECD). J. High Resol. Chromatogr. 22:1999;429-437.
50. Hensley K., Carney J.M., Mattson M.P., Aksenova M., Harris M., Wu J.F.et al. A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proc. Natl. Acad. Sci. USA. 91:1994;3270-3274.
51. Hensley K., Maidt M.L., Yu Z., Markesbery W.R., Floyd R.A. Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation. J. Neurosci. 18:1998;8126-8132.
52. Hensley K., Floyd R.A., Zheng N.-Y., Nael R., Robinson K.A., Nguyen X.et al. p38 Kinase is activated in the Alzheimer's disease brain. J. Neurochem. 72:1999;2053-2058.
53. Hensley K., Robinson K.A., Pye Q.N., Floyd R.A., Cheng I., Garland W.A.et al. CP1-1189 inhibits interleukin 1β-induced p38-mitogen-activated protein kinase phosphorylation: an explanation for its neuroprotective properties? Neurosci. Lett. 281:2000;179-182.
54. Humphries K., Szweda L.I. Selective inactivation of α-ketoglutarate dehydrogenase and pyruvate dehydrogenase: reaction of lipoic acid with 4-hydroxy-2-nonenal. Biochemistry. 37:1998;15835-15841.
55. Janus C., Pearson J., McLaurin J., Matthews P.M., Jiang Y., Schmidt S.D.et al. Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature. 408:2000;979-982.
56. Jorgensen O.S., Brooksbank B.W., Balazs R. Neuronal plasticity and astrocytic reaction in Down syndrome and Alzheimer disease. J. Neurol. Sci. 98:1990;63-79.
57. Kalaria R.N. Cerebral microvasculature and immunological factors in Alzheimer's disease. Clin. Neurosci. 1:1993;204-211.
58. Kandeel F.R., Koussa V.K.T., Swerdloff R.S. Male sexual function and its disorders: physiology, pathophysiology, clinical investigation, and treatment. Endocr. Rev. 22:2001;342-388.
59. Kato Y., Maruyama W., Naoi M., Hashizume Y., Osawa T. Immunohistochemical detection of dityrosine in lipofuscin pigments in the aged human brain. FEBS Lett. 439:1998;231-234.
60. Keller J.N., Huang F.F., Markesbery W.R. Decreased levels of proteasome activity and proteasome expression in aging spinal cord. Neuroscience. 98:2000;149-156.
61. Kotake Y., Sang H., Miyajima T., Wallis G.L. Inhibition of NF-κB, iNOS mRNA, COX II mRNA, and COX catalytic activity by phenyl-N-tert-butylnitrone (PBN). Biochim. Biophys. Acta. 1448:1998;77-84.
62. Kotake Y. Pharmacologic properties of phenyl N-tert-butylnitrone. Antioxidants Redox Signal. 1:1999;481-499.
63. Kotake Y., Sang H., Wallis G.L., Stewart C.A. Phenyl N-tert-butylnitrone provides protection from endotoxin shock through amplified production of the anti-inflammatory cytokine interleukin-10. Arch. Biochem. Biophys. 371:1999;129-131.
64. Kristal B.S., Park B.K., Yu B.P. 4-Hydroxyhexenal is a potent inducer of the mitochondrial permeability transition. J. Biol. Chem. 271:1996;6033-6038.
65. Kroemer G., Reed J.C. Mitochondrial control of cell death. Nat. Med. 6:2000;513-519.
66. Leeuwenburgh C., Wagner P., Holloszy J.O., Sohal R.S., Heinecke J.W. Caloric restriction attenuates dityrosine cross-linking of cardiac and skeletal muscle proteins in aging mice. Arch. Biochem. Biophys. 346:1997;74-80.
67. Levine R.L., Berlett B.S., Moskovitz J., Mosoni L., Stadtman E.R. Methionine residues may protect proteins from critical oxidative damage. Mech. Ageing Dev. 107:1999;323-332.
68. Levine R.L., Oliver C.N., Fulks R.M., Stadtman E.R. Turnover of bacterial glutamine synthetase: oxidative inactivation precedes proteolysis. Proc. Natl. Acad. Sci. USA. 78:1981;2120-2124.
69. Liu P.K., Hsu C.Y., Dizdaroglu M., Floyd R.A., Kow Y.W., Karakaya A.et al. Damage, repair, and mutagenesis in nuclear genes after mouse forebrain ischemia-reperfusion. J. Neurosci. 16:1996;6795-6806.
70. Lucas D.T., Szweda L.I. Declines in mitochondrial respiration during cardiac reperfusion: age-dependent inactivation of α-ketoglutarate dehydrogenase. Proc. Natl. Acad. Sci. USA. 96:1999;6689-6693.
71. Marcillat O., Zhang Y., Lin S.W., Davies K.J.A. Mitochondria contain a proteolytic system which can recognize and degrade oxidatively-denatured proteins. Biochem. J. 254:1988;677-683.
72. Mark R.J., Lovell M.A., Markesbery W.R., Uchida K., Mattson M.P. A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid β-peptide. J. Neurochem. 68:1997;255-264.
73. Markesbery W.R. Oxidative stress hypothesis in Alzheimer's disease. Free Radic. Biol. Med. 23:1997;134-147.
74. Markesbery W.R., Lovell M. 4-Hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease. Neurobiol. Aging. 19:1998;33-36.
75. Mattson M.P., Duan W., Pedersen W.A., Culmsee C. Neurodegenerative disorders and ischemic brain diseases. Apoptosis. 6:2001;69-81.
76. Mattson M.P., Duan W., Lee J., Guo Z. Suppression of brain aging and neurodegenerative disorders by dietary restriction and environmental enrichment: molecular mechanisms. Mech. Ageing Dev. 122:2001;757-778.
77. McGeer E.G., McGeer P.L. Brain inflammation in Alzheimer disease and the therapeutic implications. Curr. Pharma. Design. 5:1999;821-836.
78. McGeer P.L., McGeer E.G. Inflammation of the brain in Alzheimer's disease: implications for therapy. J. Leukoc. Biol. 65:1999;409-415.
79. McNeal M.G., Zareparsi S., Camicioli R., Dame A., Howieson D., Quinn J.et al. Predictors of healthy brain aging. J. Gerontol.: Biol. Sci. 56A:2001;B294-B301.
80. Montine K.S., Reich E., Neely M.D., Sidell K.R., Olson S.J., Markesbery W.R.et al. Distribution of reducible 4-hydroxynonenal adduct immunoreactivity in Alzheimer disease is associated with APOE genotype. J. Neuropathol. Exp. Neurol. 57:1998;415-425.
81. Montine T.J., Montine K.S., Olson S.J., Graham D.G., Roberts L.J. II, Morrow J.et al. Increased cerebral cortical lipid peroxidation and abnormal phospholipids in aged homozygous apoE-deficient C57BL/6J mice. Exp. Neurol. 158:1999;234-241.
82. Morgan D., Diamond D.M., Gottschall P.E., Ugen K.E., Dickey C., Hardy J.et al. Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature. 408:2000;982-985.
83. Nakae D., Yasushi M., Kobayashi E., Noguchi O., Konishi Y. Improved genomic/nuclear DNA extraction for 8-hydroxydeoxyguanosine analysis of small amounts of rat liver tissue. Cancer Lett. 97:1995;233-239.
84. Nakae D., Akai H., Kishida H., Kusuoka O., Tsutsumi M., Konishi Y. Age and organ dependent spontaneous generation of nuclear 8-hydroxydeoxyguanosine in male Fischer 344 rats. Lab. Invest. 80:2000;249-261.
85. O'Banion M.K., Finch C.E. Inflammatory mechanisms and anti-inflammatory therapy in Alzheimer's disease. Neurobiol. Aging. 17:1996;669-671.
86. Papa S., Skulachev V.P. Reactive oxygen species, mitochondria, apoptosis, and aging. Mol. Cell. Biochem. 174:1997;305-319.
87. Pasinetti G.M. Cycloxygenase and Alzheimer's disease: implications for preventive initiatives to slow the progression of clinical dementia. Arch. Gerontol. Geriatr. 33:2001;13-28.
88. Perez-Campo R., Lopex-Torres M., Cadenas S., Rojas C., Barja G. The rate of free radical production as a determinant of the rate of aging: evidence from the comparative approach. J. Comp. Physiol. B. 168:1998;149-158.
89. Petropoulos I., Mary J., Perichon M., Friguet B. Rat peptide methionine sulphoxide reductase: cloning of the cDNA, and down-regulation of gene expression and enzyme activity during aging. Biochem. J. 355:2001;819-825.
90. Pizzimenti S., Barrera G., Dianzani M.U., Brusselbach S. Inhibition of D1, D2, and a cyclin expression in HL-60 cells by the lipid peroxidation product 4-hydroxynonenal. Free Radic. Biol. Med. 26:1999;1578-1586.
91. Reich E.E., Zackert W.E., Brame C.J., Chen Y., Roberts L.J. II, Hachey D.L.et al. Formation of novel D-ring and E-ring isoprostane-like compounds (D4/E4-neuroprostanes) in vivo from docosahexaenoic acid. Biochemistry. 39:2000;2376-2383.
92. Reich E.E., Markesbery W.R., Roberts L.J. II, Swift L.L., Morrow J.D., Montine T.J. Brain regional quantification of F-ring and D/E-ring isoprostanes and neuroprostanes in Alzheimer's disease. Am. J. Pathol. 158:2001;293-297.
93. Reich E.E., Montine K.S., Gross M.D., Roberts L.J. II, Swift L.L., Morrow J.D.et al. Interactions between apolipoprotein E gene and dietary α-tocopherol influence cerebral oxidative damage in aged mice. J. Neurosci. 21:2001;5993-5999.
94. 2-isoprostanes as an index of oxidative stress in vivo. Free Radic. Biol. Med. 28:2000;505-513.
95. Roberts L.J. II, Montine T.J., Markesbery W.R., Tapper A.R., Hardy P., Chemtob S.et al. Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid. J. Biol. Chem. 273:1998;13605-13612.
96. Robinson K.A., Stewart C.A., Pye Q.N., Nguyen X., Kenney L., Salzman S.et al. Redox-sensitive protein phosphatase activity regulates the phosphorylation state of p38 protein kinase in primary astrocyte culture. J. Neurosci. Res. 55:1999;724-732.
97. Rozovsky I., Finch C.E., Morgan T.E. Age-related activation of microglia and astrocytes: in vitro studies show persistent phenotypes of aging, increased proliferation, and resistance to down-regulation. Neurobiol. Aging. 19:1998;97-103.
98. Sang H., Wallis G.L., Stewart C.A., Kotake Y. Expression of cytokines and activation of transcription factors in lipopolysaccharide-administered rats and their inhibition by phenyl N-tert-butylnitrone (PBN). Arch. Biochem. Biophys. 363:1999;341-348.
99. Sano M., Ernesto M.S., Thomas R.G., Klauber M.R., Schafer K., Grundman M.et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. New Engl. J. Med. 336:1997;1216-1222.
100. Sheu K.F., Blass J.P. The alpha-ketoglutarate dehydrogenase complex. Ann. NY Acad. Sci. 893:1999;61-78.
101. Siems W.G., Grune T., Beierl B., Zollner H., Esterbauer H. The metabolism of 4-hydroxynonenal, a lipid peroxidation product, is dependent on tumor age in Ehrlich mouse ascites cells. EXS. 62:1992;124-135.
102. +/K-ATPase. Free Radic. Biol. Med. 20:1996;215-223.
103. Smith C.D., Carney J.M., Starke-Reed P.E., Oliver C.N., Stadtman E.R., Floyd R.A.et al. Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 88:1991;10540-10543.
104. Srivastava S., Chandra A., Bhatnagar A., Srivastava S.K., Ansari N.H. Lipid peroxidation produce, 4-hydroxynonenal and its conjugate with GSH are excellent substrates of bovine lens aldose reductase. Biochem. Biophys. Res. Commun. 217:1995;741-746.
105. Stadtman E.R. Protein oxidation and aging. Science. 257:1992;1220-1224.
106. Uchida K., Stadtman E.R. Modification of histidine residues in proteins by reaction with 4-hydroxynonenal. Proc. Natl. Acad. Sci. USA. 89:1992;4544-4548.
107. Uryu K., Laurer H., McIntosh T., Pratico D., Martinez D., Leight S.et al. Repetitive mild brain trauma accelerates Aβ deposition, lipid peroxidation, and cognitive impairment in a transgenic mouse model of Alzheimer amyloidosis. J. Neurosci. 22:2002;446-454.
108. Veld B.A., Ruitenberg A., Hofman A., Launer L.J., van Duijn C.M., Breteler M.et al. Non-steroidal anti-inflammatory drugs and the risk of Alzheimer's disease. New Engl. J. Med. 345:2001;1515-1521.
109. Vernet D., Bonavera J.J., Swerdloff R.S., Gonzalez-Cadavid N.F., Wang C. Spontaneous expression of inducible nitric oxide synthase in the hypothalamus and other brain regions of aging rats. Endocrinology. 139:1998;3254-3261.
110. Wataya T, Nunomura A, Smith MA, Siedlak SL, Harris PL, Shimohama S, et al. High molecular weight neurofilament proteins are physiological substrates of adduction by the lipid peroxidation product hydroxynonel. J Biol Chem 2001. Ref ID: 26634.
111. Weninger S.C., Yankner B.A. Inflammation and Alzheimer disease: the good, the bad, and the ugly. Nat. Med. 7:2001;527-528.
112. Williams G.R. Incidence and characteristics of total stroke in the United States. BMC Neurol. 1:2001;2.
113. Wu Q., Combs C., Cannady S.B., Geldmacher D.S., Herrup K. Beta-amyloid activated microglia induce cell cycling and cell death in cultured cortical neurons. Neurobiol. Aging. 21:2000;797-806.
114. Wyss-Coray T., Lin C., Yan F., Yu G.-Q., Rohde M., McConlogue L.et al. TGF-β1 promotes microglial amyloid-β clearance and reduces plaque burden in transgenic mice. Nat. Med. 7:2001;612-618.
115. Yan L.-J., Sohal R.S. Mitochondrial adenine nucleotide translocase is modified oxidatively during aging. Proc. Natl. Acad. Sci. USA. 95:1998;12896-12901.
116. Yang Y., Geldmacher D.S., Herrup K. DNA replication precedes neuronal cell death in Alzheimer's disease. J. Neurosci. 21:2001;2661-2668.
117. Yermakova A.V., O'Banion M.K. Downregulation of neuronal cycloxygenase-II expression in end stage Alzheimer's disease. Neurobiol. Aging. 22:2001;823-836.
118. Yoritaka A., Hattori N., Uchida K., Tanaka M., Stadtman E.R., Mizuno Y. Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc. Natl. Acad. Sci. USA. 93:1996;2696-2701.
119. Zaleska M.M., Floyd R.A. Regional lipid peroxidation in rat brain in vitro: possible role of endogenous iron. Neurochem. Res. 10:1985;397-410.
120. Zhu X., Rottkamp C.A., Hartzler A., Sun Z., Takeda A., Boux H.et al. Activation of MKK6, an upstream activator of p38, in Alzheimer's disease. J. Neurochem. 79:2001;311-318.
121. Zhu X., Castellani R.J., Takeda A., Nunomura A., Atwood C.S., Perry G.et al. Differential activation of neuronal ERK, JNK/SAPK and p38 in Alzheimer disease: the 'two hit' hypothesis. Mech. Ageing Dev. 123:2001;39-46.